Edition:
United States

Momenta Pharmaceuticals Inc (MNTA.O)

MNTA.O on Nasdaq

17.15USD
22 Sep 2017
Change (% chg)

$0.35 (+2.08%)
Prev Close
$16.80
Open
$16.75
Day's High
$17.20
Day's Low
$16.65
Volume
510,672
Avg. Vol
677,835
52-wk High
$19.90
52-wk Low
$10.75

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.39 December 23 Sep 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 2 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 2 2 2
No Opinion 0 0 0 0
Mean Rating 2.80 3.14 3.14 3.14

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 2 27.11 30.95 23.28 34.59
Quarter Ending Dec-17 2 56.33 65.66 46.99 36.00
Year Ending Dec-17 5 128.65 160.00 108.00 131.68
Year Ending Dec-18 6 184.89 317.00 80.00 165.34
Earnings (per share)
Quarter Ending Sep-17 3 -0.39 -0.33 -0.45 -0.29
Quarter Ending Dec-17 3 0.02 0.47 -0.37 -0.30
Year Ending Dec-17 5 -1.39 -0.82 -1.98 -0.99
Year Ending Dec-18 6 -0.30 1.26 -2.60 -0.68

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 24.64 23.57 1.07 4.33
Quarter Ending Mar-17 24.49 26.61 2.13 8.69
Quarter Ending Dec-16 29.56 34.19 4.63 15.66
Quarter Ending Sep-16 26.05 29.14 3.09 11.87
Quarter Ending Jun-16 21.90 26.43 4.53 20.69

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 27.11 27.11 31.21 25.34 34.59
Quarter Ending Dec-17 56.33 56.33 64.70 47.29 36.00
Year Ending Dec-17 128.65 128.65 142.06 124.30 131.68
Year Ending Dec-18 184.89 184.89 189.16 175.88 165.34

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 0 0 0
Quarter Ending Dec-17 0 0 0 0
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 0 0
Earnings